Phosphate → 2-Hydroxypropanoic acid--3-({3-[(4-aminobutyl)amino]propyl}amino)-7-hydroxycholestan-24-yl hydrogen sulfate (1/1)

HRID 467406ノート

反応式

HRID 467406 の反応式
[CH3:1][C@@H:2]([C@@H:14]1[C@@:18]2([CH3:43])[CH2:19][CH2:20][C@@H:21]3[C@@:26]4([CH3:41])[CH2:27][CH2:28][C@H:29]([NH:31][CH2:32][CH2:33][CH2:34][NH:35][CH2:36][CH2:37][CH2:38][CH2:39][NH2:40])[CH2:30][C@@H:25]4[CH2:24][C@@H:23]([OH:42])[C@H:22]3[C@@H:17]2[CH2:16][CH2:15]1)[CH2:3][CH2:4][C@@H:5]([O:9][S:10]([OH:13])(=[O:12])=[O:11])[CH:6]([CH3:8])[CH3:7].[CH3:44][C@H:45]([OH:49])[C:46]([OH:48])=[O:47].[P:50]([O-:54])([O-:53])([O-:52])=[O:51].P([O-])([O-])([O-])=O.[Na+].[Na+].[Na+]>O=C[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O>[CH3:1][C@@H:2]([C@@H:14]1[C@@:18]2([CH3:43])[CH2:19][CH2:20][C@@H:21]3[C@@:26]4([CH3:41])[CH2:27][CH2:28][C@H:29]([NH:31][CH2:32][CH2:33][CH2:34][NH:35][CH2:36][CH2:37][CH2:38][CH2:39][NH2:40])[CH2:30][C@@H:25]4[CH2:24][C@@H:23]([OH:42])[C@H:22]3[C@@H:17]2[CH2:16][CH2:15]1)[CH2:3][CH2:4][C@@H:5]([O:9][S:10]([OH:13])(=[O:12])=[O:11])[CH:6]([CH3:7])[CH3:8].[CH3:44][C@H:45]([OH:49])[C:46]([OH:48])=[O:47].[CH3:1][C@@H:2]([C@@H:14]1[C@@:18]2([CH3:43])[CH2:19][CH2:20][C@@H:21]3[C@@:26]4([CH3:41])[CH2:27][CH2:28][C@H:29]([NH:31][CH2:32][CH2:33][CH2:34][NH:35][CH2:36][CH2:37][CH2:38][CH2:39][NH2:40])[CH2:30][C@@H:25]4[CH2:24][C@@H:23]([OH:42])[C@H:22]3[C@@H:17]2[CH2:16][CH2:15]1)[CH2:3][CH2:4][C@@H:5]([O:9][S:10]([OH:13])(=[O:12])=[O:11])[CH:6]([CH3:7])[CH3:8].[P:50]([O-:54])([O-:53])([O-:52])=[O:51]

参加物

6

反応物 3

HCID 1061PhosphateHCID 24243Trisodium PhosphateHCID 30365072-Hydroxypropanoic acid--3-({3-[(4-aminobutyl)amino]propyl}amino)-7-hydroxycholestan-24-yl hydrogen sulfate (1/1)2 回

生成物 2

HCID 30365072-Hydroxypropanoic acid--3-({3-[(4-aminobutyl)amino]propyl}amino)-7-hydroxycholestan-24-yl hydrogen sulfate (1/1)HCID 86653613HCID 86653613、化合物

試薬・触媒・溶媒 1

HCID 107526(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal溶媒

実験手順

A 10 mg/ml solution of squalamine lactate was prepared in 5% dextrose. A squalamine phosphate suspension was prepared by adjusting the 10 mg/ml squalamine lactate solution to 50 mM phosphate by addition of 1M sodium phosphate, pH 7.4. 0.1 ml of each preparation was then separately injected into the subcutaneous space between the thumb and second finger of a healthy human subject with a syringe bearing a 26 gauge needle. Within seconds of injection of the squalamine lactate solution, the subject experienced an intense stinging sensation not unlike an insect sting. This sensation persisted for about 20 minutes. Over the course of the following 24 hours the site became tender, swollen, and visibly red. These signs and symptoms persisted for about 1 week, gradually diminishing in intensity.

後処理

  1. customsubject with a syringe
  2. customOver the course of the following 24 hours
  3. waitThese signs and symptoms persisted for about 1 week

出典と根拠

ORDレコード
ord-6edf2a5ad7274373baa01fed4332c23e
出典データセット
uspto-grants-2014_01
特許番号
US08623416B2

反応ノート

読み込み中…